Related Experiment Video
Updated: Feb 8, 2026

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes
Published on: May 25, 2022
Inflammation leads through PGE/EP3 signaling to HDAC5/MEF2-dependent transcription in cardiac myocytes
András D Tóth1,2,3, Richard Schell1,2,4, Magdolna Lévay2,5
1Department of Molecular Cardiology and Epigenetics, Heidelberg University, Heidelberg, Germany.
Abstract:
The myocyte enhancer factor 2 (MEF2) regulates transcription in cardiac myocytes and adverse remodeling of adult hearts. Activators of G protein-coupled receptors (GPCRs) have been reported to activate MEF2, but a comprehensive analysis of GPCR activators that regulate MEF2 has to our knowledge not been performed. Here, we tested several GPCR agonists regarding their ability to activate a MEF2 reporter in neonatal rat ventricular myocytes. The inflammatory mediator prostaglandin E2 (PGE2) strongly activated MEF2. Using pharmacological and protein-based inhibitors, we demonstrated that PGE2 regulates MEF2 via the EP3 receptor, the βγ subunit of Gi/o protein and two concomitantly activated downstream pathways. The first consists of Tiam1, Rac1, and its effector p21-activated kinase 2, the second of protein kinase D. Both pathways converge on and inactivate histone deacetylase 5 (HDAC5) and thereby de-repress MEF2. In vivo, endotoxemia in MEF2-reporter mice induced upregulation of PGE2 and MEF2 activation. Our findings provide an unexpected new link between inflammation and cardiac remodeling by de-repression of MEF2 through HDAC5 inactivation, which has potential implications for new strategies to treat inflammatory cardiomyopathies.
Insights
Inflammation activates cardiac myocyte enhancer factor 2 (MEF2) via prostaglandin E2 (PGE2) and EP3 receptors. This pathway involves G protein signaling, leading to histone deacetylase 5 (HDAC5) inactivation and MEF2 de-repression, impacting cardiac remodeling.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Inflammation Research
Background:
- Myocyte enhancer factor 2 (MEF2) is crucial for cardiac myocyte transcription and adverse cardiac remodeling.
- G protein-coupled receptor (GPCR) activators are known to influence MEF2 activity, but a systematic analysis is lacking.
Purpose of the Study:
- To comprehensively analyze GPCR agonists that regulate MEF2 activity.
- To elucidate the signaling pathways linking GPCR activation to MEF2 in cardiac myocytes.
Main Methods:
- Utilized neonatal rat ventricular myocytes with a MEF2 reporter assay.
- Employed pharmacological and protein-based inhibitors to dissect signaling cascades.
- Investigated endotoxemia in MEF2-reporter mice to assess in vivo relevance.
Main Results:
- Prostaglandin E2 (PGE2) strongly activated MEF2.
- PGE2-induced MEF2 activation occurred via the EP3 receptor and G(i/o) protein.
- Two downstream pathways, involving Tiam1/Rac1/PAK2 and Protein Kinase D, converged to inactivate Histone Deacetylase 5 (HDAC5), de-repressing MEF2.
- Endotoxemia in vivo upregulated PGE2 and activated MEF2.
Conclusions:
- PGE2, through EP3 receptor and specific downstream signaling, inactivates HDAC5 to de-repress MEF2 in cardiac myocytes.
- This study reveals an unexpected link between inflammation and cardiac remodeling via MEF2 regulation.
- Findings suggest potential therapeutic strategies for inflammatory cardiomyopathies targeting this pathway.
Related Concept Videos
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Master Transcription Regulators
Inflammation
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...

